Cierra N. Sharp

Cierra N. Sharp

Jun 14, 2016

Group 6 Copy 17
0
    Please wait...

    About This Project

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Round Goby assault on American rivers: How fast, how far, how complete?

    After conquering the Great Lakes, what will the invasive Round Goby do to fish in our streams? Four years...

    A Bird's-eye View of Frog Habitats: Using a Drone to Survey Wetlands

    I study vulnerable frog species that inhabit human-constructed wetlands in the Grand River Grasslands of...

    Short-Term Innovative Research (STIR): Predoctoral Grant Competition

    Writing grants is the number one skill required for a successful independent scientist. This project provides...

    Backer Badge Funded